Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
about
Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivationA novel function of tissue-type transglutaminase: protein disulphide isomeraseTransglutaminases: nature's biological gluesTissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's diseaseTransglutaminase 2-mediated serotonylation in pulmonary hypertensionStructural Characterization of a Conserved, Calcium-Dependent Periplasmic Protease from Legionella pneumophilaA novel transglutaminase activator forms a complex with type 1 transglutaminaseProtein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional proteinCellular functions of tissue transglutaminaseThe mitogen-activated protein kinase kinase kinase dual leucine zipper-bearing kinase (DLK) acts as a key regulator of keratinocyte terminal differentiationRole of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cellsFunctional coupling of rat myometrial alpha 1-adrenergic receptors to Gh alpha/tissue transglutaminase 2 during pregnancyPhospholipase C, Ca2+, and calmodulin signaling are required for 5-HT2A receptor-mediated transamidation of Rac1 by transglutaminaseLigand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data.Effects of the regulatory ligands calcium and GTP on the thermal stability of tissue transglutaminase.Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes.Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury.Intracellular localization and conformational state of transglutaminase 2: implications for cell death.Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.Inosine monophosphate dehydrogenase: A molecular switch integrating pleiotropic GTP-dependent beta-cell functions.Transglutaminase regulation of cell function.Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.A nonradioactive dot blot assay for transglutaminase activityTransglutaminases (TGs) in ocular and periocular tissues: effect of muscarinic agents on TGs in scleral fibroblasts.Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation.Alpha1B-adrenoceptor signaling and cell motility: GTPase function of Gh/transglutaminase 2 inhibits cell migration through interaction with cytoplasmic tail of integrin alpha subunits.Transglutaminase 2 and phospholipase A₂ interactions in the inflammatory response in human Thp-1 monocytes.Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic interventionTransglutaminase 2 inhibitors and their therapeutic role in disease states.Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.Inhibition of tissue transglutaminase promotes Aβ-induced apoptosis in SH-SY5Y cells.Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregatesTissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues.Transglutaminase activation in neurodegenerative diseases.Potential of transglutaminase 2 as a therapeutic target.Transglutaminase as a therapeutic target for celiac disease.Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetesmiR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.
P2860
Q21560855-642546FA-53E6-4A4E-BEBC-675021CFC9A4Q24530143-245E5A1E-2165-458F-B146-F78EFDC2C482Q24534936-5E496483-270B-4001-A3EC-544BD463BA1EQ24618141-36F9CD52-6F30-47F2-9A14-E3B5DC0D1CB5Q27027862-E42327AC-4983-4D85-9C12-DE0CB330BBB2Q27681211-F48EBFB6-4EAD-4167-A855-8D099451A24EQ28246458-8F0AAA09-C1D2-46DB-AD1D-D6B0D0E58180Q28247511-7A001283-A93F-486A-9645-3780EB3729A2Q28260600-8BE4A718-B724-43BF-8A41-D38186502D5AQ28306267-C84AA092-7326-49AA-8067-6EE5F953B26BQ28364936-49928D6B-5BB0-4C04-9AF0-2D8041F67ED3Q28484010-B1A0BADD-99B6-47BB-ABB0-F04780BEC4C7Q28567816-CCD7EF08-5B52-4314-8083-EF0564B370CDQ28571141-67887C6C-D349-4883-B2E0-8A227D0A79D4Q30326841-F16045CC-047A-4113-9E08-90601F025CB5Q30404253-70FDFB95-A429-4D0C-9AF1-9C8614F213E6Q33187633-B13DFDEF-5F81-4470-9253-44C80CD628CFQ33262164-2700AF39-6A33-4E2F-9CEF-A00DC85183A4Q33325485-1F4C755E-BDA6-4DF9-9E02-9192F8AB3A85Q33476870-27A4F39E-4474-4ABE-9BAF-D5F2DD7AB064Q33536410-3E498E1F-8E76-43E5-907C-D459AFC058FCQ33694089-7EA28250-AF7B-44D4-A900-F9FDB7F5F28BQ33707936-4F2EC300-74B8-4B8C-A5A0-126DE73A6890Q33737470-5DE86598-386B-4AA4-A7D4-B9256659B86DQ33752028-FBABBDAC-4909-451D-ADD2-CA90F7ED68B0Q33873741-75ADC582-889B-4D5C-BC35-E84BC1ABE2DAQ34196409-DADEE0F9-7A78-4067-ACB7-901B3AB8CA02Q34329442-B17033F8-B6F1-4342-94C7-D4BBE65F8512Q34891892-EC0CBC22-DB5F-4926-BF43-C745D7BFB14EQ34927039-66CDC510-2F59-4636-A631-44CAA7214090Q35989247-90DF2434-4175-4342-B914-51655D17CDBEQ36073969-B137BDF0-1C4C-4784-AB9E-81BA98424F0DQ36144015-669A7AEC-9DAE-4FF8-A9E7-D8CF6CBBDE90Q36342395-B26EA077-04BF-43C6-AAD9-0182526D84ABQ37111745-7E5B4379-2E49-4EDB-BEEF-E0D0F337DEABQ37352964-5DD10B20-A36D-415A-B230-D339E85D3AE1Q37776508-D2EA98B6-769D-470E-8B9E-3875D4AB0824Q38269678-7AF59175-8AF0-4AA8-AEFA-CB7FE4CE9E5BQ38771484-00277C78-6FEE-48B8-860A-8E12B62AF7C1Q38879949-59BBAE39-5FA5-4F26-9E49-A93DF4B2DCDF
P2860
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
@en
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
@nl
type
label
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
@en
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
@nl
prefLabel
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
@en
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
@nl
P2093
P2860
P356
P1476
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
@en
P2093
P2860
P304
P356
10.1074/JBC.273.4.2288
P407
P577
1998-01-01T00:00:00Z